Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02734160
Title A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
Honor Health Research Institute Scottsdale Arizona 85258 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Gustave Roussy Villejuif Cedex 94805 France Details
Ospedale Policlinico Giambattista Rossi, Borgo Roma Verona 37134 Italy Details
Samsung Medical Center Seoul Korea 06351 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Madrid Norte Sanchinarro Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field